본문 바로가기
KERD
논문KCI 등재

Research on Intracranial Atherosclerosis from the East and West: Why Are the Results Different?

김종성|David Bonovich
대한뇌졸중학회 (The Korean Stroke Society)|2014.09|대한뇌졸중영문학회지 (Journal of stroke)|제16권 제3호|pp. 105-113|DOI http://dx.doi.org/10.5853/jos.2014.16.3.105

2

조회

0

다운로드

11

인용

0

참고문헌

키워드

Risk factorsAntiplateletIntracranial atherosclerosisStentingEthnicities
주제분류신경과학

초록

Intracranial atherosclerosis (ICAS) is a major cause of stroke worldwide and is more common in Asians than Caucasians. The study results from the East and West are generally similar, but notable differences exist. For example, studies from the East have reported that ICAS is associated with young age, whereas ICAS seems to be associated with old age in the West. Studies from the East have strongly suggested that mild ICAS associated with branch occlusion is one of the main causes of single subcortical infarction, whereas this aspect has not been considered in stroke classification systems developed in the West. While clopidogrel is commonly used in patients with large artery disease in the West, cilostazol has been more extensively studied and commonly used in ICAS patients in the East. A randomized controlled study from the West reported negative results regarding the efficacy of stenting in ICAS patients due largely to a relatively high rate of periprocedural adverse events, whereas research papers from the East have reported a relatively lower rate of complications. Studies to narrow these East-West gaps should be performed, including risk factor studies using homogenous ethnic populations, studies investigating appropriate classification systems, drug trials in different ethnic populations, and rigorous high standard randomized controlled studies on the efficacy of stenting in Eastern populations.

Abstract

Intracranial atherosclerosis (ICAS) is a major cause of stroke worldwide and is more common in Asians than Caucasians. The study results from the East and West are generally similar, but notable differences exist. For example, studies from the East have reported that ICAS is associated with young age, whereas ICAS seems to be associated with old age in the West. Studies from the East have strongly suggested that mild ICAS associated with branch occlusion is one of the main causes of single subcortical infarction, whereas this aspect has not been considered in stroke classification systems developed in the West. While clopidogrel is commonly used in patients with large artery disease in the West, cilostazol has been more extensively studied and commonly used in ICAS patients in the East. A randomized controlled study from the West reported negative results regarding the efficacy of stenting in ICAS patients due largely to a relatively high rate of periprocedural adverse events, whereas research papers from the East have reported a relatively lower rate of complications. Studies to narrow these East-West gaps should be performed, including risk factor studies using homogenous ethnic populations, studies investigating appropriate classification systems, drug trials in different ethnic populations, and rigorous high standard randomized controlled studies on the efficacy of stenting in Eastern populations.

참고문헌 (81)

  1. Uehara T., "Frequency and clinical correlates of occlusive lesions of cerebral arteries in Japanese patients without stroke. Evaluation by MR angiography", Cerebrovasc Dis, 8, pp.267~272 (1998)
  2. Kim JS., "Risk factors and stroke mechanisms in atherosclerotic stroke : intracranial compared with extracranial and anterior compared with posterior circulation disease", Stroke, 43, pp.3313~3318 (2012)
  3. Kim YD., "Classic risk factors for atherosclerosis are not major determinants for location of extracranial or intracranial cerebral atherosclerosis", Neuroepidemiology, 32, pp.201~207 (2009)
  4. Kuller L., "An explanation for variations in distribution of stroke and arteriosclerotic heart disease among populations and racial groups", Am J Epidemiol, 93, pp.1~9 (1971)
  5. Caplan LR., "Race, sex and occlusive cerebrovascular disease : a review", Stroke, 17, pp.648~655 (1986)
  6. Solberg LA., "Cerebral atherosclerosis in Negroes and Caucasians", Atherosclerosis, 16, pp.141~154 (1972)
  7. Moosy J., "Development of cerebral atherosclerosis in various age groups", Neurology, 9, pp.569~574 (1959)
  8. D’Armiento FP., "Age-related effects on atherogenesis and scavenger enzymes of intracranial and extracranial arteries in men without classic risk factors for atherosclerosis", Stroke, 32, pp.2472~2479 (2001)
  9. Lei C., "Risk factors and clinical outcomes associated with intracranial and extracranial atherosclerotic stenosis acute ischemic stroke", J Stroke Cerebrovasc Dis, 23, pp.1112~1117 (2013)
  10. Huang HW., "Prevalence and risk factors of middle cerebral artery stenosis in asymptomatic residents in Rongqi County, Guangdong", Cerebrovasc Dis, 24, pp.111~115 (2007)
  11. Lopez-Cancio E., "Biological signatures of asymptomatic extra-and intracranial atherosclerosis : the Barcelona-AsIA(Asymptomatic Intracranial Atherosclerosis)study", Stroke, 43, pp.2712~2719 (2012)
  12. Bang OY., "Association of the metabolic syndrome with intracranial atherosclerotic stroke", Neurology, 65, pp.296~298 (2005)
  13. Park JH., "Metabolic syndrome is more associated with intracranial atherosclerosis than extracranial atherosclerosis", Eur J Neurol, 14, pp.379~386 (2007)
  14. Rincon F., "Incidence and risk factors of intracranial atherosclerotic stroke : the Northern Manhattan Stroke Study", Cerebrovasc Dis, 28, pp.65~71 (2009)
  15. Bang OY., "Impact of metabolic syndrome on distribution of cervicocephalic atherosclerosis : data from a diverse race-ethnic group", J Neurol Sci, 284, pp.40~45 (2009)
  16. Forouhi NG., "CVD risk factors and ethnicity--a homogeneous relationship?", Atheroscler Suppl, 7, pp.11~19 (2006)
  17. McGruder HF., "Racial and ethnic disparities in cardiovascular risk factors among stroke survivors : United States 1999 to 2001", Stroke, 35, pp.1557~1561 (2004)
  18. Chandalia M., "Relationship between generalized and upper body obesity to insulin resistance in Asian Indian men", J Clin Endocrinol Metab, 84, pp.2329~2335 (1999)
  19. Ford ES., "Prevalence of the metabolic syndrome defined by the International Diabetes Federation among adults in the U. S", Diabetes Care, 28, pp.2745~2749 (2005)
  20. Valsamakis G., "Fasting serum adiponectin concentration is reduced in Indo-Asian subjects and is related to HDL cholesterol", Diabetes Obes Metab, 5, pp.131~135 (2003)
  21. 방오영, "Intracranial Atherosclerosis: Current Understanding and Perspectives", 대한뇌졸중학회지, 16(1), pp.27~35 (2014), 대한뇌졸중학회[DOI]
  22. Suzuki J., "Cerebrovascular"moyamoya"disease. Disease showing abnormal net-like vessels in base of brain", Arch Neurol, 20, pp.288~299 (1969)
  23. Kelly ME., "Progression of unilateral moyamoya disease : a clinical series", Cerebrovasc Dis, 22, pp.109~115 (2006)
  24. Kuroda S., "Radiological findings, clinical course, and outcome in asymptomatic moyamoya disease : results of multicenter survey in Japan", Stroke, 38, pp.1430~1435 (2007)
  25. Goyal MS., "Clinical features and outcome in North American adults with idiopathic basal arterial occlusive disease without moyamoya collaterals", Neurosurgery, 67, pp.278~285 (2010)
  26. Wakai K., "Epidemiological features of moyamoya disease in Japan: findings from a nationwide survey", Clin Neurol Neurosurg, 99, pp.S1~S5 (1997)
  27. Metso TM., "Adult cervicocerebral artery dissection : a single-center study of 301 Finnish patients", Eur J Neurol, 16, pp.656~661 (2009)
  28. Huang YC., "Cervicocranial arterial dissection: experience of 73 patients in a single center", Surg Neurol, 72, pp.S20~S27 (2009)
  29. Klein IF., "In vivo middle cerebral artery plaque imaging by highresolution MRI", Neurology, 67, pp.327~329 (2006)
  30. Ryu CW., "High resolution wall and lumen MRI of the middle cerebral arteries at 3 tesla", Cerebrovasc Dis, 27, pp.433~442 (2009)
  31. Xu WH., "In vivo highresolution MR imaging of symptomatic and asymptomatic middle cerebral artery atherosclerotic stenosis", Atherosclerosis, 212, pp.507~511 (2010)
  32. Vergouwen MD., "Eccentric narrowing and enhancement of symptomatic middle cerebral artery stenoses in patients with recent ischemic stroke", Arch Neurol, 68, pp.338~342 (2011)
  33. Degnan AJ., "MR angiography and imaging for the evaluation of middle cerebral artery atherosclerotic disease", AJNR Am J Neuroradiol, 33, pp.1427~1435 (2012)
  34. Mi Kim S., "Two different morphologies of chronic unilateral middle cerebral artery occlusion : evaluation using high-resolution MRI", J Neuroimaging, 24, pp.460~466 (2014)
  35. Miki Fujimura, "Genetics and Biomarkers of Moyamoya Disease: Significance of RNF213 as a Susceptibility Gene", 대한뇌졸중학회지, 16(2), pp.65~72 (2014), 대한뇌졸중학회[DOI]
  36. Wong KS., "Mechanisms of acute cerebral infarctions in patients with middle cerebral artery stenosis : a diffusion-weighted imaging and microemboli monitoring study", Ann Neurol, 52, pp.74~81 (2002)
  37. Lee DK., "Lesion patterns and stroke mechanism in atherosclerotic middle cerebral artery disease : early diffusion-weighted imaging study", Stroke, 36, pp.2583~2588 (2005)
  38. Fisher CM., "Basilar artery branch occlusion : a cause of pontine infarction", Neurology, 21, pp.900~905 (1971)
  39. Lhermitte F., "Nature of occlusions of the middle cerebral artery", Neurology, 20, pp.82~88 (1970)
  40. Bogousslavsky J., "Atherosclerotic disease of the middle cerebral artery", Stroke, 17, pp.1112~1120 (1986)
  41. Caplan LR., "Intracranial branch atheromatous disease : a neglected, understudied, and underused concept", Neurology, 39, pp.1246~1250 (1989)
  42. Kwon SU., "Efficacy and safety of combination antiplatelet therapies in patients with symptomatic intracranial atherosclerotic stenosis", Stroke, 42, pp.2883~2890 (2011)
  43. Adachi T., "MRI findings of small subcortical"lacunar-like"infarction resulting from large vessel disease", J Neurol, 247, pp.280~285 (2000)
  44. Bang OY., "Middle cerebral artery stenosis is a major clinical determinant in striatocapsular small, deep infarction", Arch Neurol, 59, pp.259~263 (2002)
  45. Mok VC., "Small subcortical infarct and intracranial large artery disease in Chinese", J Neurol Sci, 216, pp.55~59 (2003)
  46. Cho AH., "Is 15 mm size criterion for lacunar infarction still valid? A study on strictly subcortical middle cerebral artery territory infarction using diffusion-weighted MRI", Cerebrovasc Dis, 23, pp.14~19 (2007)
  47. Ryoo S., "Branch occlusive disease : clinical and magnetic resonance angiography findings", Neurology, 78(12), pp.888~896 (2012)
  48. Kim JS., "Single subcortical infarction associated with parental arterial disease : important yet neglected sub-type of atherothrombotic stroke", Int J Stroke, 8, pp.197~203 (2013)
  49. Yoon Y., "Single subcortical infarction and atherosclerotic plaques in the middle cere-bral artery : high-resolution magnetic resonance imaging findings", Stroke, 44, pp.2462~2467 (2013)
  50. 김범준, "Ischemic Stroke Subtype Classification: An Asian Viewpoint", 대한뇌졸중학회지, 16(1), pp.8~17 (2014), 대한뇌졸중학회[DOI]
  51. Adams HP. Jr., "Classification of subtype of acute ischemic stroke. Definitions for use in a multicenter clinical trial. TOAST. Trial of Org 10172 in Acute Stroke Treatment", Stroke, 24, pp.35~41 (1993)
  52. Ay H., "An evidence-based causative classification system for acute ischemic stroke", Ann Neurol, 58, pp.688~697 (2005)
  53. Amarenco P., "New approach to stroke subtyping : the A-S-C-O(phenotypic)classification of stroke", Cerebrovasc Dis, 27, pp.502~508 (2009)
  54. Kim JT., "Subtyping of ischemic stroke based on vascular imaging : analysis of 1, 167 acute, consecutive patients", J Clin Neurol, 2, pp.225~230 (2006)
  55. Han SW., "A new subtype classification of ischemic stroke based on treatment and etiologic mechanism", Eur Neurol, 57, pp.96~102 (2007)
  56. Gao S., "Chinese ischemic stroke subclassification", Front Neurol, 2, pp.6~ (2011)
  57. Diener HC., "Aspirin and clopidogrel compared with clopidogrel alone after recent ischaemic stroke or transient ischaemic attack in high-risk patients(MATCH) : randomised, doubleblind, placebo-controlled trial", Lancet, 364, pp.331~337 (2004)
  58. Bhatt DL., "Clopidogrel and aspirin versus aspirin alone for the prevention of atherothrombotic events", N Engl J Med, 354, pp.1706~1717 (2006)
  59. Benavente OR., "Effects of clopidogrel added to aspirin in patients with recent lacunar stroke", N Engl J Med, 367, pp.817~825 (2012)
  60. Markus HS., "Dual antiplatelet therapy with clopidogrel and aspirin in symptomatic carotid stenosis evaluated using doppler embolic signal detection : the Clopidogrel and Aspirin for Reduction of Emboli in Symptomatic Carotid Stenosis(CARESS)trial", Circulation, 111, pp.2233~2240 (2005)
  61. Wong KS., "Clopidogrel plus aspirin versus aspirin alone for reducing embolisation in patients with acute symptomatic cerebral or carotid artery stenosis(CLAIR study) : a randomised, open-label, blinded-endpoint trial", Lancet Neurol, 9, pp.489~497 (2010)
  62. Wang Y., "Clopidogrel with aspirin in acute minor stroke or transient ischemic attack", N Engl J Med, 369, pp.11~19 (2013)
  63. Gotoh F., "Cilostazol stroke prevention study : a placebo-controlled double-blind trial for secondary prevention of cerebral infarction", J Stroke Cerebrovasc Dis, 9, pp.147~157 (2000)
  64. Shinohara Y., "Cilostazol for prevention of secondary stroke(CSPS 2) : an aspirin-controlled, double-blind, randomised noninferiority trial", Lancet Neurol, 9, pp.959~968 (2010)
  65. Kwon SU., "Cilostazol prevents the progression of the symptomatic intracranial arterial stenosis : the multicenter double-blind placebo-controlled trial of cilostazol in symptomatic intracranial arterial stenosis", Stroke, 36, pp.782~786 (2005)
  66. Lee YS., "Cilostazol in Acute Ischemic Stroke Treatment(CAIST Trial) : a randomized double-blind non-inferiority trial", Cerebrovasc Dis, 32, pp.65~71 (2011)
  67. Huang Y., "Cilostazol as an alternative to aspirin after ischaemic stroke : a randomised, double-blind, pilot study", Lancet Neurol, 7, pp.494~499 (2008)
  68. Kim JS., "Cilostazol : a drug particularly effective for Asians?", Int J Stroke, 6, pp.209~210 (2011)
  69. Chimowitz MI., "Stenting versus aggressive medical therapy for intracranial arterial stenosis", N Engl J Med, 365, pp.993~1003 (2011)
  70. Derdeyn CP., "Aggressive medical treatment with or without stenting in high-risk patients with intracranial artery stenosis(SAMMPRIS) : the final results of a randomised trial", Lancet, 383, pp.333~341 (2014)
  71. "Zhonghua Wai Ke Za Zhi", 2004, 169~172
  72. Suh DC., "Intracranial stenting of severe symptomatic intracranial stenosis : results of 100 consecutive patients", AJNR Am J Neuroradiol, 29, pp.781~785 (2008)
  73. Yu SC., "Angioplasty and stenting of atherosclerotic middle cerebral arteries with Wingspan : evaluation of clinical outcome, restenosis, and procedure outcome", AJNR Am J Neuroradiol, 32, pp.753~758 (2011)
  74. Jiang WJ., "Outcome of patients with ≥70% symptomatic intracranial stenosis after Wingspan stenting", Stroke, 42, pp.1971~1975 (2011)
  75. Kim KS., "Usefulness of stent implantation for treatment of intracranial atherosclerotic stenoses", Neurointervention, 7, pp.27~33 (2012)
  76. Mohammadian R., "A comparison of stent implant versus medical treatment for severe symptomatic intracranial stenosis : a controlled clinical trial", Cerebrovasc Dis Extra, 2, pp.108~120 (2012)
  77. Zhang L., "A single-center study of Wingspan stents for symptomatic atherosclerotic stenosis of the middle cerebral artery", J Clin Neurosci, 20, pp.362~366 (2013)
  78. Alurkar A., "Role of balloon-expandable stents in intracranial atherosclerotic disease in a series of 182 patients", Stroke, 44, pp.2000~2003 (2013)
  79. Cho AH., "Reperfusion injury on magnetic resonance imaging after carotid revascularization", Stroke, 45, pp.602~604 (2014)
  80. Yu SC., "Angioplasty and stenting for intracranial atherosclerotic stenosis : position statement of the Hong Kong Society of Interventional and Therapeutic Neuroradiology", Hong Kong Med J, 19, pp.69~73 (2013)
  81. Gandini R., "Intracranial atheromatous disease treatment with the Wingspan stent system : evaluation of clinical, procedural outcome and restenosis rate in a single-center series of 21 consecutive patients with acute and mid-term results", Clin Neurol Neurosurg, 115, pp.741~747 (2013)

관련 논문AI추천

Intracranial Atherosclerosis: Current Understanding and Perspectives방오영대한뇌졸중학회 · 대한뇌졸중영문학회지2014 · 제16권 제1호Ischemic Stroke Subtype Classification: An Asian Viewpoint김범준, 김종성대한뇌졸중학회 · 대한뇌졸중영문학회지2014 · 제16권 제1호Diagnostic and Therapeutic Strategies for Acute Intracranial Atherosclerosis-related Occlusions이진수, 홍지만, Jong S. Kim대한뇌졸중학회 · 대한뇌졸중영문학회지2017 · 제19권 제2호Considerations When Subtyping Ischemic Stroke in Asian Patients방오영대한신경과학회 · Journal of Clinical Neurology2016 · 제12권 제2호Medical Treatment of Intracranial Atherosclerosis: An Update방오형, Jong S. Kim대한뇌졸중학회 · 대한뇌졸중영문학회지2017 · 제19권 제3호Intracranial Atherosclerosis: Where Are We Now?Jong S. Kim대한뇌졸중학회 · 대한뇌졸중영문학회지2017 · 제19권 제3호

이 간행물의 다른 논문 (12건)

Stroke Genetics: A Review and UpdateArne Lindgrenpp. 114-123Isolated Vascular Vertigo이형pp. 124-130Magnetic Resonance Imaging in Acute Ischemic Stroke TreatmentSteven Warach, 강현구, 강동화, 안성호, 김범준, 김혜진, 김나영pp. 131-145Critical Care for Patients with Massive Ischemic Stroke고윤석, H. Alex Choi, 전상범, 이기원pp. 146-160MRI-based Algorithm for Acute Ischemic Stroke Subtype Classification신동익, 이경복, 이수주, 김동억, 배희준, 차재관, 한문구, 강규식, 홍근식, 고영채, 이준영, 유경호, 이병철, 김대현, 이준, 김준태, 조용진, 정종원, 이지성, 최재철, 박상순, 박종무, 박태환pp. 161-172
원문 보기